Title page of AMCP and FormularyDecision Webinar

Breaking Down the Complexities of Product Evaluation in the Digital Era

An AMCP Webinar hosted by FormularyDecisions® The product review process is complex and can vary between organizations. Join us as our expert panel outlines best practices for conducting a comprehensive product review. Our panel represents the managed care organization and biopharma company viewpoints to discuss current challenges and opportunities to streamline the product review process; including ways to incorporate digital tools.
Managed Care Practice Issues
AMCP Podcast Series Featured Episode

The Buzz Around Biosimilars: AMCP’s Actions for 2023

2023 will be a pivotal year for biosimilar success or failure. Health care expert Fred Goldstein sits down with Stanton Mehr of Biosimilars Review & Report, to discuss what lies in store for biosimilars and AMCP’s biosimilar initiatives this year.
AMCP Podcast Series Featured Episode

Digital Therapeutics: Implications for Managed Care Pharmacy in 2023

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Jennifer Graff, Senior Director of Professional Affairs at AMCP, to discuss trends to be watching regarding digital therapeutics and managed care pharmacy in 2023.
AMCP Regulatory NewsBreaks

Feb. 9, 2023: CMS Posted Information Collection Materials for the New Manufacturer Discount Program

The Inflation Reduction Act (IRA) requires the establishment of a new Medicare Part D manufacturer discount program (MDP) beginning Jan. 1, 2025 and requires participating manufacturers to enter into agreements with CMS by Mar. 1, 2024 in order to participate in the MDP in 2025. Agreements will be valid for not less than one year and automatically renew unless terminated by CMS or the manufacturer.
AMCP Regulatory NewsBreaks

Feb. 6, 2023: CMS Released the RADV Final Rule

On Feb. 1, the Final Rule, titled Medicare and Medicaid Programs; Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Program of AllInclusive Care for the Elderly (PACE), Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021, was published in the Federal Register.